Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Multiple Sclerosis Gene Uncovered After 30-year Search

30.07.2007
For the first time in more than three decades, a multi-center team of researchers has uncovered a gene linked to multiple sclerosis (MS) that could pave the way for future research and treatment options.

Nature Genetics and the New England Journal of Medicine are publishing two separate but related studies today that report the most significant MS genetic breakthrough since the 1970s and only the second MS genetic risk factor confirmed through research.

Researchers from Vanderbilt University, the University of Miami, the University of California at San Francisco, Duke University, and the University of Cambridge participated in both studies.

The Nature Genetics paper “provides solid genetic and functional evidence that the interleukin 7 receptor (IL7R) alpha chain gene is associated with MS” said co-corresponding author Jonathan Haines, Ph.D., director of the Center for Human Genetics Research at Vanderbilt. This specific genetic variation can increase an individual’s risk of getting MS by about 20 percent, he said.

... more about:
»Complex »IL7R »confirmed

“The genetics of MS has been very difficult to crack,” said Haines, also senior corresponding author of the NEJM paper that further confirmed this result.

“This is the first MS-associated gene outside of the major histocompatibility complex (MHC) that has been confirmed in multiple populations.” said co-corresponding author Margaret Pericak-Vance, Ph.D., director of the Miami Institute for Human Genomics at the Miami Miller School of Medicine and co-leader of the project while working at Duke University.

These researchers collective 15 years of research, supported by the National Institutes of Health, focused on the analysis of more than 10,000 DNA samples from MS patients and unaffected individuals.

The group used a powerful technique called “genomic convergence” that integrates multiple sources and types of evidence to implicate candidate genes in complex diseases.

“We took a very systematic approach, we looked at multiple lines of evidence that would give us the best chances of successfully identifying a gene that was truly involved in MS susceptibility,” said Pericak-Vance.

"We have identified the first gene to be genetically and functionally implicated in the development of MS in the last 30 years,” said Simon Gregory, Ph.D., assistant professor at the Center for Human Genetics, Duke University, and first author of the paper.

“Now we need to identify the reasons why this gene, which plays an intimate part in the normal functioning of the immune system, may be involved in this complex and devastating disease. IL7R will ultimately be only one of a number of genes involved in the development of MS."

The MS Group collaborated with scientists in the United Kingdom and Belgium to confirm the IL7R association. No other genes – of the more than 100 that have been associated with the disease – have reached consensus.

The International Multiple Sclerosis Genetics Consortium (IMSGC) in the NEJM paper confirmed these findings by using a technique called “whole genome association” that scans the entire human genome for variants that associated with MS. This effort also identified a statistical association with the IL7R gene, along with another previously suspected gene, IL2R.

Between 1972 and 1975 researchers found that a variant of the human leukocyte antigen (HLA-DRB1) increases the likelihood of getting the disease up to fourfold. When combined with IL7R, these two genes increase the risk of getting MS by fivefold, researchers said.

MS is an unpredictable, chronic inflammatory disease of the central nervous system that affects about 350,000 individuals in the United States. It is thought to result from a complex interplay of genetics and environmental triggers. Symptoms include visual problems, muscle weakness and disability.

| newswise
Further information:
http://www.mc.vanderbilt.edu/npa

Further reports about: Complex IL7R confirmed

More articles from Life Sciences:

nachricht Climate Impact Research in Hannover: Small Plants against Large Waves
17.08.2018 | Leibniz Universität Hannover

nachricht First transcription atlas of all wheat genes expands prospects for research and cultivation
17.08.2018 | Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>